Kumar Kothapalli

Kumar Kothapalli serves as Chief Medical Officer at Biophore India Pharmaceuticals Pvt. Ltd. since January 2024 and also holds the position of Scientific Advisor at the Institute of Genetics & Hospital for Genetic Diseases, where efforts focus on reducing the genetic disease burden in society. Previously, Kumar Kothapalli was Associate Professor/Associate Scientist V at The University of Texas at Austin from July 2017 to January 2024 and held roles as Senior Research Associate and Research Associate at Cornell University from November 2004 to June 2017. Kumar Kothapalli's educational background includes a Post-Doctoral Fellowship in Genetics and Genomics from Cornell University, a PhD in Human/Medical Genetics from Osmania University, an MS in Human/Medical Genetics from Andhra University, and a BS in Botany, Zoology, and Chemistry from Andhra University.